These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 17873029)

  • 1. Nutritional cues control Pseudomonas aeruginosa multicellular behavior in cystic fibrosis sputum.
    Palmer KL; Aye LM; Whiteley M
    J Bacteriol; 2007 Nov; 189(22):8079-87. PubMed ID: 17873029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.
    Palmer KL; Mashburn LM; Singh PK; Whiteley M
    J Bacteriol; 2005 Aug; 187(15):5267-77. PubMed ID: 16030221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane phospholipid composition of Pseudomonas aeruginosa grown in a cystic fibrosis mucus-mimicking medium.
    Deschamps E; Schaumann A; Schmitz-Afonso I; Afonso C; Dé E; Loutelier-Bourhis C; Alexandre S
    Biochim Biophys Acta Biomembr; 2021 Jan; 1863(1):183482. PubMed ID: 33002450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
    Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
    Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial cyanogenesis occurs in the cystic fibrosis lung.
    Sanderson K; Wescombe L; Kirov SM; Champion A; Reid DW
    Eur Respir J; 2008 Aug; 32(2):329-33. PubMed ID: 18480103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics of Pseudomonas aeruginosa Australian epidemic strain 1 (AES-1) cultured under conditions mimicking the cystic fibrosis lung reveals increased iron acquisition via the siderophore pyochelin.
    Hare NJ; Soe CZ; Rose B; Harbour C; Codd R; Manos J; Cordwell SJ
    J Proteome Res; 2012 Feb; 11(2):776-95. PubMed ID: 22054071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa.
    Barth AL; Pitt TL
    J Med Microbiol; 1996 Aug; 45(2):110-9. PubMed ID: 8683546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
    Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
    J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-L-Lysine compacts DNA, kills bacteria, and improves protease inhibition in cystic fibrosis sputum.
    Dubois AV; Midoux P; Gras D; Si-Tahar M; Bréa D; Attucci S; Khelloufi MK; Ramphal R; Diot P; Gauthier F; Hervé V
    Am J Respir Crit Care Med; 2013 Sep; 188(6):703-9. PubMed ID: 23947381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum.
    Turner KH; Wessel AK; Palmer GC; Murray JL; Whiteley M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4110-5. PubMed ID: 25775563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputum.
    Palmer KL; Brown SA; Whiteley M
    J Bacteriol; 2007 Jun; 189(12):4449-55. PubMed ID: 17400735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung.
    Harrington NE; Sweeney E; Alav I; Allen F; Moat J; Harrison F
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33554970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretome of transmissible Pseudomonas aeruginosa AES-1R grown in a cystic fibrosis lung-like environment.
    Scott NE; Hare NJ; White MY; Manos J; Cordwell SJ
    J Proteome Res; 2013 Dec; 12(12):5357-69. PubMed ID: 23991618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa Cell Membrane Protein Expression from Phenotypically Diverse Cystic Fibrosis Isolates Demonstrates Host-Specific Adaptations.
    Kamath KS; Pascovici D; Penesyan A; Goel A; Venkatakrishnan V; Paulsen IT; Packer NH; Molloy MP
    J Proteome Res; 2016 Jul; 15(7):2152-63. PubMed ID: 27246823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression of Pseudomonas aeruginosa in a mucin-containing synthetic growth medium mimicking cystic fibrosis lung sputum.
    Fung C; Naughton S; Turnbull L; Tingpej P; Rose B; Arthur J; Hu H; Harmer C; Harbour C; Hassett DJ; Whitchurch CB; Manos J
    J Med Microbiol; 2010 Sep; 59(Pt 9):1089-1100. PubMed ID: 20522626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two NAD-independent l-lactate dehydrogenases drive l-lactate utilization in Pseudomonas aeruginosa PAO1.
    Wang Y; Xiao D; Liu Q; Zhang Y; Hu C; Sun J; Yang C; Xu P; Ma C; Gao C
    Environ Microbiol Rep; 2018 Oct; 10(5):569-575. PubMed ID: 30066495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of antimicrobial-resistant Pseudomonas aeruginosa from sputa of cystic fibrosis patients by culture on selective media.
    Perry JD; Laine L; Hughes S; Nicholson A; Galloway A; Gould FK
    J Antimicrob Chemother; 2008 May; 61(5):1057-61. PubMed ID: 18316821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
    Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
    Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.